Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

Gene expression-driven diagnostics and pharmacogenomics in cancer.

Wang Y.

Curr Opin Mol Ther. 2005 Jun;7(3):246-50. Review.

PMID:
15977422
2.

Genomic and proteomic technologies for individualisation and improvement of cancer treatment.

Wulfkuhle J, Espina V, Liotta L, Petricoin E.

Eur J Cancer. 2004 Nov;40(17):2623-32. Review.

PMID:
15541963
3.

Microarrays for cancer diagnosis and classification.

Perez-Diez A, Morgun A, Shulzhenko N.

Adv Exp Med Biol. 2007;593:74-85. Review.

PMID:
17265718
5.

Pattern identification and classification in gene expression data using an autoassociative neural network model.

Bicciato S, Pandin M, Didonè G, Di Bello C.

Biotechnol Bioeng. 2003 Mar 5;81(5):594-606.

PMID:
12514809
6.

cDNA microarrays: identification of gene signatures and their application in clinical practice.

Magic Z, Radulovic S, Brankovic-Magic M.

J BUON. 2007 Sep;12 Suppl 1:S39-44. Review.

PMID:
17935276
7.

Clinical application of cDNA microarrays in oncology.

Pusztai L, Ayers M, Stec J, Hortobágyi GN.

Oncologist. 2003;8(3):252-8. Review.

8.

Pharmacogenomics.

Ross JS, Schenkein DP, Kashala O, Linette GP, Stec J, Symmans WF, Pusztai L, Hortobagyi GN.

Adv Anat Pathol. 2004 Jul;11(4):211-20. Review.

PMID:
15220824
9.

Determination of tumour marker genes from gene expression data.

Cuperlovic-Culf M, Belacel N, Ouellette RJ.

Drug Discov Today. 2005 Mar 15;10(6):429-37. Review.

PMID:
15808822
10.
11.

Personalised medicine for cancer: from drug development into clinical practice.

Jain KK.

Expert Opin Pharmacother. 2005 Aug;6(9):1463-76. Review.

PMID:
16086635
12.

Gene expression profiling of primary breast cancer.

Rouzier R, Wagner P, Morandi P, Pusztai L.

Curr Oncol Rep. 2005 Jan;7(1):38-44. Review.

PMID:
15610685
13.

[Differential gene expression analysis by DNA microarrays technology and its application in molecular oncology].

Frolov AE, Godwin AK, Favorova OO.

Mol Biol (Mosk). 2003 Jul-Aug;37(4):573-84. Review. Russian.

PMID:
12942629
14.

Clinical pharmacogenomics and transcriptional profiling in early phase oncology clinical trials.

Burczynski ME, Oestreicher JL, Cahilly MJ, Mounts DP, Whitley MZ, Speicher LA, Trepicchio WL.

Curr Mol Med. 2005 Feb;5(1):83-102. Review.

PMID:
15720272
15.

DNA microarrays in clinical oncology.

Ramaswamy S, Golub TR.

J Clin Oncol. 2002 Apr 1;20(7):1932-41. Review.

PMID:
11919254
16.

DNA-microarrays as tools for the identification of tumor specific gene expression profiles: applications in tumor biology, diagnosis and therapy.

Staege MS, Hattenhorst UE, Neumann UE, Hutter C, Foja S, Burdach S.

Klin Padiatr. 2003 May-Jun;215(3):135-9.

PMID:
12838936
17.
18.

Gene expression profiling as a tool for basic analysis and clinical application of human cancer.

García-Escudero R, Paramio JM.

Mol Carcinog. 2008 Aug;47(8):573-9. doi: 10.1002/mc.20430.

PMID:
18324660
19.

DualChip microarray as a new tool in cancer research.

Gillet JP, de Longueville F, Remacle J.

Expert Rev Mol Diagn. 2006 May;6(3):295-306. Review.

PMID:
16706734
20.

Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.

Auman JT, McLeod HL.

Drug Metab Rev. 2008;40(2):303-15. doi: 10.1080/03602530801952427 . Review.

PMID:
18464047
Items per page

Supplemental Content

Write to the Help Desk